Nature Communications (Jun 2023)
Addendum to: Improved CRISPR genome editing using small highly active and specific engineered RNA-guided nucleases
- Moritz J. Schmidt,
- Ashish Gupta,
- Christien Bednarski,
- Stefanie Gehrig-Giannini,
- Florian Richter,
- Christian Pitzler,
- Michael Gamalinda,
- Christina Galonska,
- Ryo Takeuchi,
- Kui Wang,
- Caroline Reiss,
- Kerstin Dehne,
- Michael J. Lukason,
- Akiko Noma,
- Cindy Park-Windhol,
- Mariacarmela Allocca,
- Albena Kantardzhieva,
- Shailendra Sane,
- Karolina Kosakowska,
- Brian Cafferty,
- Jan Tebbe,
- Sarah J. Spencer,
- Scott Munzer,
- Christopher J. Cheng,
- Abraham Scaria,
- Andrew M. Scharenberg,
- André Cohnen,
- Wayne M. Coco
Affiliations
- Moritz J. Schmidt
- Bayer AG
- Ashish Gupta
- Bayer AG
- Christien Bednarski
- Bayer AG
- Stefanie Gehrig-Giannini
- Bayer AG
- Florian Richter
- Bayer AG
- Christian Pitzler
- Bayer AG
- Michael Gamalinda
- Bayer AG
- Christina Galonska
- Bayer AG
- Ryo Takeuchi
- Casebia Therapeutics LLC
- Kui Wang
- Casebia Therapeutics LLC
- Caroline Reiss
- Casebia Therapeutics LLC
- Kerstin Dehne
- Bayer AG
- Michael J. Lukason
- CRISPR Therapeutics INC
- Akiko Noma
- Casebia Therapeutics LLC
- Cindy Park-Windhol
- Casebia Therapeutics LLC
- Mariacarmela Allocca
- Casebia Therapeutics LLC
- Albena Kantardzhieva
- Casebia Therapeutics LLC
- Shailendra Sane
- Casebia Therapeutics LLC
- Karolina Kosakowska
- Casebia Therapeutics LLC
- Brian Cafferty
- Casebia Therapeutics LLC
- Jan Tebbe
- Bayer AG
- Sarah J. Spencer
- CRISPR Therapeutics INC
- Scott Munzer
- Casebia Therapeutics LLC
- Christopher J. Cheng
- Casebia Therapeutics LLC
- Abraham Scaria
- Casebia Therapeutics LLC
- Andrew M. Scharenberg
- Casebia Therapeutics LLC
- André Cohnen
- Bayer AG
- Wayne M. Coco
- Bayer AG
- DOI
- https://doi.org/10.1038/s41467-023-39141-w
- Journal volume & issue
-
Vol. 14,
no. 1
pp. 1 – 1
Abstract
No abstracts available.
